Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease

被引:131
作者
Green, AJE
Harvey, RJ
Thompson, EJ
Rossor, MN
机构
[1] Natl Hosp Neurol & Neurosurg, Dept Neuroimmunol, London WC1N 3BG, England
[2] St Marys, Imperial Coll Sch Med, London WC1N 3BG, England
[3] Natl Hosp Neurol & Neurosurg, Dementia Res Grp, London WC1N 3BG, England
关键词
cerebrospinal fluid; tau; frontotemporal dementia; Alzheimer's disease; Pick's disease; dementia;
D O I
10.1016/S0304-3940(98)00904-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cerebrospinal fluid (CSF) concentrations of tau protein were measured using an enzyme-linked immunosorbent assay which measures both normal and hyperphosphorylated tau. Levels of CSF tau were measured in 17 patients with Alzheimer's disease and 23 patients with frontotemporal dementia, and were compared to age-matched healthy controls. The CSF tau concentration in control subjects was 198 +/- 49 pg/ml and no relationship was found between age and CSF tau concentrations in these subjects. CSF tau concentrations were significantly raised in patients with both Alzheimer's disease and frontotemporal dementia when compared to healthy controls (802 +/- 381 pg/ml, P < 0.001; 612 +/- 382 pg/ml, P < 0.05, respectively). In neither disease did CSF tau correlate with disease severity as assessed by the Mini Mental State Examination score (MMSE), This study shows that CSF tau is significantly raised in patients with frontotemporal dementia. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 135
页数:3
相关论文
共 20 条
  • [1] Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study
    Andreasen, N
    Vanmechelen, E
    Van de Voorde, A
    Davidsson, P
    Hesse, C
    Tarvonen, S
    Räihä, I
    Sourander, L
    Winblad, B
    Blennow, K
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) : 298 - 305
  • [2] TAU IN CEREBROSPINAL-FLUID - A POTENTIAL DIAGNOSTIC MARKER IN ALZHEIMERS-DISEASE
    ARAI, H
    TERAJIMA, M
    MIURA, L
    HIGUCHI, S
    MURAMATSU, T
    MACHIDA, N
    SEIKI, H
    TAKASE, S
    CLARK, CM
    LEE, VMY
    TROJANOWSKI, JQ
    SASAKI, H
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (04) : 649 - 652
  • [3] Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
    Arai, H
    Morikawa, Y
    Higuchi, M
    Matsui, T
    Clark, CM
    Miura, M
    Machida, N
    Lee, VMY
    Trojanowski, JQ
    Sasaki, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 262 - 264
  • [4] tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease?
    Blennow, K
    Wallin, A
    Agren, H
    Spenger, C
    Siegfried, J
    Vanmechelen, E
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 26 (03) : 231 - 245
  • [5] BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416
  • [6] CORRELATIONS OF SYNAPTIC AND PATHOLOGICAL MARKERS WITH COGNITION OF THE ELDERLY
    DICKSON, DW
    CRYSTAL, HA
    BEVONA, C
    HONER, W
    VINCENT, I
    DAVIES, P
    [J]. NEUROBIOLOGY OF AGING, 1995, 16 (03) : 285 - 298
  • [7] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN
    FOLSTEIN, MF
    FOLSTEIN, SE
    MCHUGH, PR
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) : 189 - 198
  • [8] Assessment of CSF levels of tan protein in mildly demented patients with Alzheimer's disease
    Galasko, D
    Clark, C
    Chang, L
    Miller, B
    Green, RC
    Motter, R
    Seubert, P
    [J]. NEUROLOGY, 1997, 48 (03) : 632 - 635
  • [9] MOLECULAR CHARACTERIZATION OF MICROTUBULE-ASSOCIATED PROTEINS-TAU AND MAP2
    GOEDERT, M
    CROWTHER, RA
    GARNER, CC
    [J]. TRENDS IN NEUROSCIENCES, 1991, 14 (05) : 193 - 199
  • [10] GOEDERT M, 1993, TINS, V11, P460